We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Kimberly Clark Corp | NYSE:KMB | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 134.29 | 33 | 13:01:12 |
From May 2019 to May 2024
By Allison Prang
Kimberly-Clark Corp.'s (KMB) profit rose as the company reported $175 million in other income, helping boost profit as net sales grew just over 1%.
The drug company's profit was $671 million, up 49% from the comparable quarter a year earlier. Earnings were $1.94 a share, up from $1.29 a share.
Adjusted earnings were $1.84 a share, up from $1.71 a share. Analysts polled by FactSet were expecting $1.80 a share.
Net sales were $4.64 billion, up 1.3%. Analysts were expecting $4.65 billion.
Kimberly-Clark reported net other income of $175 million up from $2 million a year earlier. The company said that includes about a $182 million gain before tax from selling "a manufacturing facility and associated real estate."
Gross profit also rose as the company's cost of products sold declined.
Write to Allison Prang at allison.prang@wsj.com
(END) Dow Jones Newswires
October 22, 2019 08:02 ET (12:02 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year Kimberly Clark Chart |
1 Month Kimberly Clark Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
